Amir Tavakkol

Amir Tavakkol has an extensive background in the pharmaceutical industry, with a focus on drug development for dermatological conditions. With experience in companies such as Moberg Pharma AB, Timber Pharmaceuticals, and Castle Creek Pharmaceuticals, Amir has held leadership roles such as Chief Scientific Officer and Executive Vice President. Throughout their career, Amir has led various successful drug development efforts and clinical trials for a range of treatments, including antifungal drugs and skin diseases. Amir's educational background includes a Ph.D. in Medical Microbiology from The University of Manchester, further showcasing their expertise in the field.